|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.710 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 789,963 | -10.280% | 880,480 | 1,088,426 | 1,094,328 | 846,397 |
| Cost of Sales | (371,775) | -6.580% | (397,962) | (461,380) | (419,365) | (341,214) |
| Gross Profit | 418,188 | -13.332% | 482,518 | 627,046 | 674,963 | 505,183 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 4 | -- | (2,772) | (4,100) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 13,534 | 2155.667% | 600 | 105,019 | 167,819 | 95,414 | |
| Taxation | (4,469) | -- | 8,217 | (20,767) | (31,667) | (17,875) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 51 | -- | (34) | (812) | (1,252) | (491) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 9,116 | 3.791% | 8,783 | 83,440 | 134,900 | 77,048 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,144 | 50.526% | 760 | 1,735 | 45 | 1,076 |
| Depreciation & Amortisation | 46,434 | -2.050% | 47,406 | 51,053 | 50,015 | 45,934 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 1.100 | 10.000% | 1.000 | 9.900 | 15.900 | 9.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 5.502 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 34.604% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.276 | -- | 1.257 | 1.282 | 1.237 | 1.129 |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 9,116 |
| %Change | 3.791% |
| EPS / (LPS) | RMB 0.011 |
| NBV Per Share (¥) | RMB 1.276 |